Federal Register / Vol. 79, No. 216 / Friday, November 7, 2014 / Notices 66383 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2014–26510 Filed 11–6–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) 

In accordance with section 10(a) (2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned committee: 

Times and Dates 

9:00 a.m.–5:00 p.m., December 4, 2014 

9:00 a.m.–12:00 p.m., December 5, 2014 

Place: Emory Conference Center, The 

Silverbell Pavilion, 1615 Clifton Rd, Atlanta, 

Georgia, 30329. 

Status: Open to the public, limited only by 

the space available. Please register for the 

meeting at www.cdc.gov/hicpac. 

Purpose: The Committee is charged with 

providing advice and guidance to the 

Director, Division of Healthcare Quality 

Promotion, the Director, National Center for 

Emerging and Zoonotic Infectious Diseases 

(NCEZID), the Director, CDC, the Secretary, 

Health and Human Services regarding (1) the 

practice of healthcare infection prevention 

and control; (2) strategies for surveillance, 

prevention, and control of infections, 

antimicrobial resistance, and related events 

in settings where healthcare is provided; and 

(3) periodic updating of CDC guidelines and 

other policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters for Discussion: The agenda will 

include updates on CDC’s activities for 

prevention of healthcare associated 

infections (HAIs), updates on antimicrobial 

resistance, an update on Draft Guidelines, 

and updates on healthcare preparedness and 

emerging infections. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: Erin 

Stone, M.S., HICPAC, Division of Healthcare 

Quality Promotion, NCEZID, CDC, l600 

Clifton Road NE., Mailstop A–07, Atlanta, 

Georgia 30333 Telephone (404) 639–4045. 

Email: hicpac@cdc.gov 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Claudette Grant, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention (CDC). 

[FR Doc. 2014–26511 Filed 11–6–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10371] 

Emergency Clearance: Public 

Information Collection Requirements 

Submitted to the Office of Management 

and Budget (OMB) 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

any of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

We are, however, requesting an 

emergency review of the information 

collection referenced below. In 

compliance with the requirement of 

section 3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, we have 

submitted to the Office of Management 

and Budget (OMB) the following 

requirements for emergency review. 

This is necessary to ensure compliance 

with an initiative of the Administration. 

We are requesting an emergency review 

under 5 CFR Part 1320(a)(2)(i) because 

public harm is reasonably likely to 

result if the normal clearance 

procedures are followed. We are seeking 

emergency approval for modifications to 

the information collection request (ICR) 

currently approved under Office of 

Management and Budget (OMB) control 

number 0938–1119 in order to 

collection additional information during 

the 2015 open enrollment periods from 

the 14 operational SBMs (including 

Washington, DC) to enhance the 

agency’s understanding of the 

demographic makeup of the citizens 

enrolling in the various health plans as 

well as the affordability of those plans. 

Existing collections gather information 

from the grant awardee to ensure the 

CMS is able to conduct their statutory 

oversight responsibilities. The revision 

to the weekly reporting requirement is 

necessary to obtain more accurate and 

consistent enrollment data during the 

upcoming Open Enrollment Period 

which begins November 15, 2014. The 

immediate need for this revision is due 

to the State-Based Marketplaces (SBM) 

maturing business processes and the 

requirement for more precise reporting 

of comparison data between the first 

and second years of ACA 

implementation. The changes to the 

revised format of the Weekly Report 

have been presented to all participating 

states. CMS is requesting an emergency 

modification to the weekly reporting 

template in order to capture certain 

demographic data and information on 

new versus re-enrolled individuals in 

accordance with uniform definitions so 

as not to produce misleading results. 

DATES: Comments must be received by 

November 14, 2014. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: CMS–10371/OMB Control 

Number 0938–1119, Room C4–26–05, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following 

mstockstill on DSK4VPTVN1PROD with NOTICES

66384 Federal Register / Vol. 79, No. 216 / Friday, November 7, 2014 / Notices 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/Paperwork

ReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10371 Cooperative Agreement 

To Support Establishment of StateOperated Health Insurance Exchanges 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. In 

compliance with the requirement of 

section 3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, we have 

submitted to the Office of Management 

and Budget (OMB) the following 

requirements for emergency review. 

This is necessary to ensure compliance 

with an initiative of the Administration. 

We are requesting an emergency review 

under 5 CFR Part 1320(a)(2)(i) because 

public harm is reasonably likely to 

result if the normal clearance 

procedures are followed. 

Information Collection 

1. Type of Information Collection 

Request: Revision of a currently 

approved information collection; Title 

of Information Collection: Cooperative 

Agreement to Support Establishment of 

State-Operated Health Insurance 

Exchanges; Use: Section 1311 of the 

Affordable Care Act provides for grants 

to States for the planning and 

establishment of Marketplaces. Given 

the innovative nature of Marketplaces 

and the statutorily-prescribed 

relationship between the Secretary and 

States in their development and 

operation, it has been critical that the 

Secretary work closely with States to 

provide necessary guidance and 

technical assistance to ensure that States 

can meet the prescribed timelines, 

federal requirements, and goals of the 

statute. These grants are funded through 

the Health Insurance Marketplaces 

Cooperative Agreement to Support 

Establishment of the Affordable Care 

Act’s Health Insurance Exchanges 

(Funding Opportunity Number: IE– 

HBE–12–001). A critical part of this 

guidance and assistance is the collection 

of precise information to measure the 

performance of the individual 

exchanges. 

The revised data collection 

instrument has been developed in 

coordination with the states, based on 

an understanding of their current data 

collection efforts and capabilities. The 

tool will enable us to: (1) Distinguish 

new enrollees from renewals; (2) 

capture language preference (Spanish, 

other language, or no preference) to 

assist in targeting potentially 

underserved individuals; (3) obtain a 

better understanding of enrollment 

activity by certain demographic 

breakdowns to better target our 

activities through more refined crosstabulations of data by age and gender, 

by age and Metal Level, and by financial 

assistance status (with/without) and 

Metal Level; (4) distinguish Special 

Enrollment Period activity for the 2014 

coverage year during the period that 

overlaps with the first 2.5 months of 

Open Enrollment [November 15- 

December 31] in order to avoid 

contamination of 2015 data, to assess 

the extent of Special Enrollment activity 

during the last phase of 2014 activity; 

(5) identify stand-alone dental plans to 

better measure the extent to which 

individuals are enrolling in these 

products in order to provide input into 

ASPE’s monthly report to the public; (6) 

codify providing enrollment data for all 

issuers in the individual marketplaces, 

if available, compared to the template 

that asks only for the top three in the 

individual marketplaces [These data, if 

available, have been provided to us as 

a write-in to the previous template on a 

voluntary basis.]. Form Number: CMS– 

10371 (OMB control number: 0938– 

1119); Frequency: Weekly; Affected 

Public: State, Local or Tribal 

Governments; Number of Respondents: 

16; Total Annual Responses: 208; Total 

Annual Hours: 6,240. (For policy 

questions regarding this collection 

contact Dena Puskin 301–492–4342.) 

We are requesting OMB review and 

approval of this collection by November 

15, 2014, with a 180-day approval 

period. Written comments and 

recommendations will be considered 

from the public if received by the date 

and address noted above. 

Dated: November 4, 2014. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2014–26584 Filed 11–5–14; 4:15 pm] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2014–N–0001] 

Anti-Infective Drugs Advisory 

Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Anti-Infective 

Drugs Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the Agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on December 5, 2014, from 8 a.m. 

to 4:30 p.m. 

Location: The Marriott Inn and 

Conference Center, University of 

Maryland University College, The 

Ballroom, 3501 University Blvd. East, 

Adelphi, MD 20783. The conference 

center’s telephone number is 301–985– 

7300. 

Contact Person: Jennifer Shepherd, 

Center for Drug Evaluation and 

Research, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Silver Spring, MD 20993–0002, 

301–796–9001, Fax: 301–847–8533, 

AIDAC@fda.hhs.gov, or FDA Advisory 

Committee Information Line, 1–800– 

741–8138 (301–443–0572 in the 

Washington, DC area). A notice in the 

Federal Register about last minute 

modifications that impact a previously 

announced advisory committee meeting 

cannot always be published quickly 

enough to provide timely notice. 

Therefore, you should always check the 

Agency’s Web site at http://

www.fda.gov/AdvisoryCommittees/

default.htm and scroll down to the 

appropriate advisory committee meeting 

link, or call the advisory committee 

information line to learn about possible 

modifications before coming to the 

meeting. 

mstockstill on DSK4VPTVN1PROD with NOTICES